Form 8-K - Current report:
SEC Accession No. 0001493152-26-033173
Filing Date
2026-07-14
Accepted
2026-07-14 16:01:28
Documents
12
Period of Report
2026-07-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 37844
2 EX-10.1 ex10-1.htm EX-10.1 44012
  Complete submission text file 0001493152-26-033173.txt   258836

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ppcb-20260708.xsd EX-101.SCH 3011
4 XBRL LABEL FILE ppcb-20260708_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE ppcb-20260708_pre.xml EX-101.PRE 22356
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3190
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-42806 | Film No.: 261174273
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)